JP Morgan Chase’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $159M | Buy |
8,201,220
+5,569,621
| +212% | +$110M | 0.01% | 789 |
|
|
2025
Q4 | $49.8M | Sell |
2,631,599
-957,654
| -27% | -$17.7M | ﹤0.01% | 1369 |
|
|
2025
Q3 | $66.9M | Buy |
3,589,253
+903,841
| +34% | +$16.9M | ﹤0.01% | 1226 |
|
|
2025
Q2 | $49.5M | Sell |
2,685,412
-1,301,649
| -33% | -$23.1M | ﹤0.01% | 1334 |
|
|
2025
Q1 | $69.7M | Sell |
3,987,061
-6,325,930
| -61% | -$107M | 0.01% | 1129 |
|
|
2024
Q4 | $179M | Buy |
10,312,991
+426,074
| +4% | +$7.78M | 0.01% | 700 |
|
|
2024
Q3 | $184M | Buy |
9,886,917
+6,819,919
| +222% | +$115M | 0.01% | 718 |
|
|
2024
Q2 | $47.2M | Sell |
3,066,998
-7,201,609
| -70% | -$103M | ﹤0.01% | 1279 |
|
|
2024
Q1 | $152M | Buy |
10,268,607
+3,560,545
| +53% | +$49.3M | 0.01% | 757 |
|
|
2023
Q4 | $95.7M | Sell |
6,708,062
-6,796,358
| -50% | -$96.5M | 0.01% | 911 |
|
|
2023
Q3 | $188M | Buy |
13,504,420
+11,835,109
| +709% | +$151M | 0.02% | 571 |
|
|
2023
Q2 | $19.6M | Sell |
1,669,311
-527,611
| -24% | -$6.01M | ﹤0.01% | 1710 |
|
|
2023
Q1 | $25.3M | Buy |
2,196,922
+148,480
| +7% | +$1.84M | ﹤0.01% | 1498 |
|
|
2022
Q4 | $25.5M | Buy |
2,048,442
+366,295
| +22% | +$4.67M | ﹤0.01% | 1477 |
|
|
2022
Q3 | $22.1M | Buy |
1,682,147
+466,102
| +38% | +$6.89M | ﹤0.01% | 1508 |
|
|
2022
Q2 | $17M | Sell |
1,216,045
-1,242,361
| -51% | -$16.6M | ﹤0.01% | 1733 |
|
|
2022
Q1 | $36.6M | Sell |
2,458,406
-1,012,579
| -29% | -$13.9M | ﹤0.01% | 1343 |
|
|
2021
Q4 | $47M | Buy |
3,470,985
+1,033,788
| +42% | +$14.6M | 0.01% | 1245 |
|
|
2021
Q3 | $35.9M | Sell |
2,437,197
-595,767
| -20% | -$10.1M | ﹤0.01% | 1357 |
|
|
2021
Q2 | $55.2M | Buy |
3,032,964
+101,842
| +3% | +$1.81M | 0.01% | 1177 |
|
|
2021
Q1 | $50.9M | Buy |
2,931,122
+839,966
| +40% | +$14.8M | 0.01% | 1156 |
|
|
2020
Q4 | $36.3M | Buy |
2,091,156
+90,150
| +5% | +$1.44M | 0.01% | 1240 |
|
|
2020
Q3 | $27.9M | Buy |
2,001,006
+486,536
| +32% | +$7.15M | ﹤0.01% | 1280 |
|
|
2020
Q2 | $21.9M | Sell |
1,514,470
-1,006,286
| -40% | -$13.2M | ﹤0.01% | 1320 |
|
|
2020
Q1 | $27.5M | Buy |
2,520,756
+289,057
| +13% | +$5.33M | 0.01% | 1073 |
|
|
2019
Q4 | $47.6M | Sell |
2,231,699
-264,469
| -11% | -$5.92M | 0.01% | 992 |
|
|
2019
Q3 | $57.3M | Buy |
2,496,168
+641,314
| +35% | +$13.7M | 0.01% | 880 |
|
|
2019
Q2 | $36.1M | Buy |
1,854,854
+869,179
| +88% | +$16.9M | 0.01% | 1164 |
|
|
2019
Q1 | $19.2M | Sell |
985,675
-521,755
| -35% | -$9.89M | ﹤0.01% | 1567 |
|
|
2018
Q4 | $24.8M | Sell |
1,507,430
-272,263
| -15% | -$5.48M | 0.01% | 1320 |
|
|
2018
Q3 | $41.1M | Buy |
1,779,693
+1,226,574
| +222% | +$27.8M | 0.01% | 1127 |
|
|
2018
Q2 | $12M | Buy |
553,119
+232,420
| +72% | +$4.54M | ﹤0.01% | 1994 |
|
|
2018
Q1 | $5.66M | Sell |
320,699
-35,311
| -10% | -$622K | ﹤0.01% | 2478 |
|
|
2017
Q4 | $6.68M | Sell |
356,010
-537,233
| -60% | -$10.7M | ﹤0.01% | 2436 |
|
|
2017
Q3 | $19.3M | Buy |
893,243
+876,089
| +5,107% | +$19.8M | ﹤0.01% | 1518 |
|
|
2017
Q2 | $413K | Sell |
17,154
-147,874
| -90% | -$3.76M | ﹤0.01% | 3795 |
|
|
2017
Q1 | $4.61M | Sell |
165,028
-191,935
| -54% | -$5.03M | ﹤0.01% | 2492 |
|
|
2016
Q4 | $8.72M | Buy |
356,963
+214,684
| +151% | +$4.92M | ﹤0.01% | 2017 |
|
|
2016
Q3 | $3.58M | Sell |
142,279
-521,860
| -79% | -$12.5M | ﹤0.01% | 2456 |
|
|
2016
Q2 | $13.7M | Buy |
664,139
+282,887
| +74% | +$5.9M | ﹤0.01% | 1655 |
|
|
2016
Q1 | $7.66M | Buy |
381,252
+80,793
| +27% | +$1.55M | ﹤0.01% | 1944 |
|
|
2015
Q4 | $6.08M | Buy |
300,459
+14,944
| +5% | +$315K | ﹤0.01% | 2099 |
|
|
2015
Q3 | $6.62M | Buy |
+285,515
| New | +$7.29M | ﹤0.01% | 2046 |
|
|
2015
Q2 | – | Sell |
-700,400
| Closed | -$23.2M | – | 4150 |
|
|
2015
Q1 | $23.2M | Buy |
+700,400
| New | +$22.7M | 0.01% | 1332 |
|
|
2014
Q4 | – | Sell |
-19,463
| Closed | -$473K | – | 4341 |
|
|
2014
Q3 | $473K | Buy |
19,463
+9,411
| +94% | +$261K | ﹤0.01% | 3695 |
|
|
2014
Q2 | $289K | Buy |
+10,052
| New | +$292K | ﹤0.01% | 3286 |
|
|
2014
Q1 | – | Sell |
-66,141
| Closed | -$1.73M | – | 3887 |
|
|
2013
Q4 | $1.73M | Sell |
66,141
-50,428
| -43% | -$1.3M | ﹤0.01% | 2836 |
|
|
2013
Q3 | $2.68M | Sell |
116,569
-57,837
| -33% | -$1.43M | ﹤0.01% | 2608 |
|
|
2013
Q2 | $4.55M | Buy |
+174,406
| New | +$5.03M | ﹤0.01% | 2202 |
|
Other funds holding SBRA
VPM
VCM
N
CIM
JP Morgan Chase's SBRA Position: Q1 2026 in Review
JP Morgan Chase increased its Sabra Healthcare REIT (SBRA) stake by 212% in Q1 2026, buying an estimated $110M and bringing the position to 8,201,220 shares worth $159M. The position accounts for 0.01% of the portfolio, ranked #789.
JP Morgan Chase first reported a position in SBRA in Q2 2013 and has held it in 49 quarters since. The position peaked at $188M in Q3 2023. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- JP Morgan Chase held 8,201,220 shares of Sabra Healthcare REIT worth $159M as of Q1 2026.
- JP Morgan Chase bought 5,569,621 Sabra Healthcare REIT shares in Q1 2026, an estimated $110M.
- Sabra Healthcare REIT made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #789 holding.
- JP Morgan Chase first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 49 quarters since.
- JP Morgan Chase's Sabra Healthcare REIT position peaked at $188M in Q3 2023.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.